ICMR says that the vaccine for children will be available by September

Zydus Cadila is the vaccine producer working on one of the vaccines for children.

The National Institute of Virology in ICMR announced that phase 2 and phase 3 of clinical trials are currently going on. The results will be released once the trials are concluded. Also, the vaccine can be expected by September.

Presently, the vaccination drive in India has been expedited. But only 2 vaccines are being administered in India. These are Covaxin and Covishield. Both these vaccines have been in short supply recently. The international vaccines by Pfizer and Johnson & Johnson are still pending approval from the government over the indemnity clause.

If the trials are successful, the new vaccines are expected in September. The new vaccine will be for children below the age of 18. The experts have warned earlier that the upcoming Delta variant will affect children the most. However, there is no concrete data on that conclusion. Children from ages 2-18 will be eligible for the upcoming vaccine.

The company by the name of Zydus Cadila is the producer of this vaccine for children. There is another nasal vaccine being developed for children by the Bharat Biotech. Before the end of the year, there will be 2-3 more vaccines that will be introduced in India.

The following YouTube video by ‘India Today’ talking about the vaccines being developed for children.

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button
Join WhatsApp group
Skip to content